نتائج البحث - "Benjamin M. Ellingson"

1

Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement

المؤلفون: Kan Gao, Gregory D. Gudleski, Arpana Gupta, Bruce D. Naliboff, Ravi Bhatt, Jonathan P. Jacobs, Jennifer S. Labus, Jacob Brawer, Rebecca Firth, Kirsten Tillisch, Benjamin M. Ellingson, Venu Lagishetty, Emeran A. Mayer, Jeffrey M. Lackner

المصدر: Microbiome, Vol 9, Iss 1, Pp 1-14 (2021)
Microbiome
Microbiome, vol 9, iss 1

مصطلحات موضوعية: Microbiology (medical), Oncology, medicine.medical_specialty, 16S, medicine.medical_treatment, Clinical Trials and Supportive Activities, Neuroimaging, Biology, Microbiology, behavioral disciplines and activities, Oral and gastrointestinal, law.invention, White matter, Irritable Bowel Syndrome, Microbial ecology, Randomized controlled trial, law, Clinical Research, Internal medicine, RNA, Ribosomal, 16S, Basal ganglia, Brain-Gut Axis, medicine, Humans, Microbiome, Irritable bowel syndrome, Default mode network, Nutrition, Ribosomal, Cognitive Behavioral Therapy, Ecology, Research, QR100-130, Neurosciences, Outcome prediction, medicine.disease, Gastrointestinal Microbiome, Cognitive behavioral therapy, medicine.anatomical_structure, Mental Health, Medical Microbiology, RNA, Brain-gut-microbiome axis, Digestive Diseases, Mind and Body, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11dc14853a20c8ae18f699b3020e7b7dTest
https://doaj.org/article/9211767c78c54222a359b868989af16aTest

2

Sex-Dependent Cortical Volume Changes in Patients with Degenerative Cervical Myelopathy

المؤلفون: Langston T. Holly, Chencai Wang, Noriko Salamon, Benjamin M. Ellingson, Talia Oughourlian

المصدر: Journal of Clinical Medicine
Volume 10
Issue 17
Journal of Clinical Medicine, Vol 10, Iss 3965, p 3965 (2021)
Journal of clinical medicine, vol 10, iss 17

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a5c5ccbccf5062295f50babb12d72dTest

3

NIMG-28. VALIDATION OF MODIFIED RESPONSE ASSESSMENT IN NEURO ONCOLOGY (mRANO) DETERMINED PFS AS A STRONG PREDICTOR OF OVERALL SURVIVAL IN RECURRENT GLIOBLASTOMA TREATED WITH A TARGETED IMMUNOTOXIN

المؤلفون: Benjamin M. Ellingson, Fahar Merchant, Melissa Coello, Nina Merchant, Chandtip Chandhasin

المصدر: Neuro Oncol

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Neurologic Oncology, business.industry, Neuro oncology, medicine.medical_treatment, Recurrent glioblastoma, Neuroimaging, Immunotherapy, Response assessment, Immunotoxin, Interleukin-4 receptor, Internal medicine, Overall survival, medicine, Neurology (clinical), business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b215180262a345d957fd7dbd461b8ab6Test
https://europepmc.org/articles/PMC7651053Test/

4

RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

المصدر: Neuro Oncol

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Internal medicine, Recurrent glioblastoma, medicine, Neurology (clinical), Newly diagnosed, business, Randomized Trials in Development, Agile software development

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b701b2a693fe7768971406bfd39415fTest
https://europepmc.org/articles/PMC7651338Test/

5

Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas

المؤلفون: Matthew Ji, Linda M. Liau, Akifumi Hagiwara, David Nathanson, Whitney B. Pope, Noriko Salamon, Jingwen Yao, Catalina Raymond, Albert Lai, Talia Oughourlian, Benjamin M. Ellingson, Timothy F. Cloughesy, Phioanh L. Nghiemphu

المصدر: Neuroradiology
Neuroradiology, vol 63, iss 6

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Reversible transverse relaxation rate, Clinical Sciences, Article, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, Rare Diseases, 0302 clinical medicine, Clinical Research, Internal medicine, Glioma, Tumor Microenvironment, Medicine, Humans, Radiology, Nuclear Medicine and imaging, Epidermal growth factor receptor, Hypoxia, Survival analysis, Cancer, Tumor microenvironment, biology, business.industry, Proportional hazards model, Brain Neoplasms, Neurosciences, Spin-and-gradient echo echo-planar imaging, medicine.disease, Magnetic Resonance Imaging, Brain Disorders, Brain Cancer, ErbB Receptors, Oxygen, Nuclear Medicine & Medical Imaging, biology.protein, Human epidermal growth factor receptor, Neurology (clinical), Relative oxygen extraction fraction, Cardiology and Cardiovascular Medicine, business, Perfusion, 030217 neurology & neurosurgery, Oxygen extraction

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06d0323c34cbf47627091b4e5c343d4Test
https://europepmc.org/articles/PMC8071834Test/

6

Pathophysiology, Classification, and MRI Parallels in Microvascular Disease of the Heart and Brain

المؤلفون: Benjamin M. Ellingson, Michael A. Thomas, Peng Hu, Saman Hazany, Kim-Lien Nguyen

المصدر: Microcirculation
Microcirculation (New York, N.Y. : 1994), vol 27, iss 8

مصطلحات موضوعية: medicine.medical_specialty, Aging, Physiology, Ischemia, Myocardial Infarction, ischemia, 030204 cardiovascular system & hematology, Cardiovascular, Medical and Health Sciences, Article, Angina, 03 medical and health sciences, 0302 clinical medicine, Physiology (medical), Internal medicine, ferumoxytol, medicine, Dementia, 2.1 Biological and endogenous factors, Humans, Myocardial infarction, Molecular Biology, Stroke, Heart Disease - Coronary Heart Disease, medicine.diagnostic_test, Vascular disease, business.industry, Neurosciences, Brain, Magnetic resonance imaging, Heart, medicine.disease, stroke, Magnetic Resonance Imaging, microvascular disease, Brain Disorders, 4.1 Discovery and preclinical testing of markers and technologies, Heart Disease, Cardiovascular System & Hematology, Heart failure, Neurological, Microvessels, Cardiology, Biomedical Imaging, Cardiology and Cardiovascular Medicine, business, 030217 neurology & neurosurgery, 4.2 Evaluation of markers and technologies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8588c2d15c324ced5708ef661e5a9166Test
https://europepmc.org/articles/PMC7680357Test/

7

Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients

المؤلفون: Kenneth L. Subotnik, Todd A. Tishler, Catalina Raymond, Won Jong Chwa, Keith H. Nuechterlein, Faizan Anwar, Joseph Ventura, Benjamin M. Ellingson, Cathy Tran, J. Pablo Villablanca

المصدر: Schizophr Res

مصطلحات موضوعية: Male, medicine.medical_specialty, Second generation antipsychotics, medicine.medical_treatment, Precuneus, Intracortical myelin, Medical and Health Sciences, Cortical volume, Article, White matter, 03 medical and health sciences, 0302 clinical medicine, Clinical Research, Internal medicine, medicine, Humans, Gray Matter, Mri scan, Antipsychotic, Biological Psychiatry, Psychiatry, First episode, Risperidone, business.industry, Psychology and Cognitive Sciences, Neurosciences, Evaluation of treatments and therapeutic interventions, Serious Mental Illness, Magnetic Resonance Imaging, White Matter, Brain Disorders, 030227 psychiatry, Psychiatry and Mental health, Mental Health, medicine.anatomical_structure, Cross-Sectional Studies, 6.1 Pharmaceuticals, Right superior, Cardiology, Schizophrenia, business, 030217 neurology & neurosurgery, medicine.drug, Antipsychotic Agents

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df2ac3396e547e7c9c885b4be6e04b74Test
https://europepmc.org/articles/PMC7572538Test/

8

ACTR-61. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

المصدر: Neuro Oncol

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84faabc749eb31bf36bf2433c6f81cdaTest
https://europepmc.org/articles/PMC6847111Test/

9

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

المؤلفون: Ryo Nishikawa, Lauren E. Abrey, Robert J. Harris, Benjamin M. Ellingson, Roger Henriksson, Ararat Chakhoyan, Wolfgang Wick, Catalina Raymond, Olivier Chinot, Kevin Leu, Timothy F. Cloughesy, Josep Garcia, Arnav Mehta, Warren Mason, Davis C. Woodworth, Frank Saran, Whitney B. Pope

المساهمون: Institut de neurophysiopathologie (INP), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Service d’Oncologie Médicale [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Ellingson, BM; Abrey, LE; Garcia, J; Chinot, O; Wick, W; Saran, F; et al.(2018). Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo. NEURO-ONCOLOGY, 20(11), 1525-1535. doi: 10.1093/neuonc/noy064. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1c51c6bdTest
Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2018, ⟨10.1093/neuonc/noy064⟩
Neuro-Oncology, 2018, ⟨10.1093/neuonc/noy064⟩
Neuro-oncology, vol 20, iss 11

مصطلحات موضوعية: Male, Oncology, Cancer Research, [SDV]Life Sciences [q-bio], law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, 80 and over, ComputingMilieux_MISCELLANEOUS, Cancer, Aged, 80 and over, response assessment, medicine.diagnostic_test, Brain Neoplasms, Chemoradiotherapy, Middle Aged, Prognosis, Magnetic Resonance Imaging, Tumor Burden, Bevacizumab, Survival Rate, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Female, 4.2 Evaluation of markers and technologies, medicine.drug, MRI, Adult, medicine.medical_specialty, Adolescent, Oncology and Carcinogenesis, Clinical Investigations, Newly diagnosed, bevacizumab, Placebo, GBM, Young Adult, 03 medical and health sciences, Rare Diseases, Double-Blind Method, Clinical Research, Internal medicine, Temozolomide, medicine, Humans, Oncology & Carcinogenesis, Survival rate, Aged, clinical trials, business.industry, T1 subtraction, Neurosciences, glioblastoma, Magnetic resonance imaging, Brain Disorders, Brain Cancer, Clinical trial, Neurology (clinical), Glioblastoma, business, 030217 neurology & neurosurgery, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b6bd15c9d5ce9e742e59326a3e480bfTest
http://www.escholarship.org/uc/item/1c51c6bdTest

10

Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

المساهمون: Département de neurooncologie, Hôpital de la Timone [CHU - APHM] (TIMONE), Department of Radiation Sciences, Oncology, Umeå University, Department of Neurooncology, Heidelberg University Hospital [Heidelberg], Hadassah Hebrew University Medical Center [Jerusalem], Massachusetts General Hospital [Boston], Loughborough University, School of Environment and Technology, University of Sussex, Department of Molecular Medicine, Mayo Clinic, Hôpital de la Timone [CHU - APHM] ( TIMONE ), Massachusetts General Hospital [Boston] ( MGH )

المصدر: Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2018, ⟨10.1093/neuonc/noy053⟩
Neuro-Oncology, Oxford University Press (OUP), 2018, 〈10.1093/neuonc/noy053〉
Neuro-oncology, vol 20, iss 9
Ellingson, BM; Abrey, LE; Nelson, SJ; Kaufmann, TJ; Garcia, J; Chinot, O; et al.(2018). Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. NEURO-ONCOLOGY, 20(9), 1240-1250. doi: 10.1093/neuonc/noy053. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0v78z01zTest

مصطلحات موضوعية: Oncology, Male, Cancer Research, contrast-enhancing tumor volume, [SDV]Life Sciences [q-bio], Contrast Media, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, ComputingMilieux_MISCELLANEOUS, Cancer, Vorinostat, Chemoradiotherapy, Middle Aged, Prognosis, Magnetic Resonance Imaging, 3. Good health, Survival Rate, 030220 oncology & carcinogenesis, Residual, 6.1 Pharmaceuticals, Female, medicine.drug, medicine.medical_specialty, Prognostic factor, Bevacizumab, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Newly diagnosed, bevacizumab, Imaging data, GBM, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, medicine, Overall survival, Temozolomide, Humans, Oncology & Carcinogenesis, Retrospective Studies, Postoperative Care, clinical trials, [ SDV ] Life Sciences [q-bio], business.industry, T1 subtraction, Neurosciences, O-6-methylguanine-DNA methyltransferase, Evaluation of treatments and therapeutic interventions, medicine.disease, Image Enhancement, new glioblastoma, nervous system diseases, Brain Disorders, Clinical trial, Brain Cancer, Neoplasm, Neurology (clinical), business, Glioblastoma, 030217 neurology & neurosurgery, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5bde2fd7ff93ddc9c95a933bfa0dc0aTest
https://hal-amu.archives-ouvertes.fr/hal-01814367Test

تنقيح النتائج